You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Last Updated: October 25, 2020

DrugPatentWatch Database Preview

Generic Companies with Tentative Approvals for: Actavis Llc

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Actavis Llc Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Generic Name	NDA	Strength	Dosage Form
Actavis Llc	cabazitaxel	207970	60MG/6ML	INJECTABLE;INJECTION
Actavis Llc	bortezomib	208645	2.5MG/ML	INJECTABLE; INJECTION
Actavis Llc	cabazitaxel	207970	40MG/4ML	INJECTABLE;INJECTION
>Applicant	>Generic Name	>NDA	>Strength	>Dosage Form

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.